Aker BioMarine AS (AKBM.OL)
NOK 67.5
(-0.3%)
NOK 67.5
(-0.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 47.4 Million | 15.1 Million | 729 Thousand | -51.04 Million | 12.3 Million | 7.89 Million |
| Net Income | -9 Million | 10 Million | -8 Million | -5.46 Million | -23.75 Million | -1.02 Million |
| Depreciation & Amortization | 50.2 Million | 49.4 Million | 51.08 Million | 48.24 Million | 36.94 Million | 22.86 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 23 Million | -38 Million | -52.69 Million | -79.43 Million | -15.43 Million | -13.11 Million |
| Other non-cash items | -16.8 Million | -6.3 Million | 10.34 Million | -14.38 Million | 14.54 Million | -834 Thousand |
| Investing Cash Flow | -48.9 Million | -56.4 Million | -79.21 Million | -2.05 Million | -175.94 Million | -64.54 Million |
| Investments in PPE | -49.3 Million | -46.1 Million | -81.1 Million | -23.7 Million | -126.91 Million | -64.51 Million |
| Acquisitions | - | -11.1 Million | -10 Thousand | -356 Thousand | -49.28 Million | -36 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 400 Thousand | 800 Thousand | 1.9 Million | 22.01 Million | 254 Thousand | 6000.00 |
| Financing Cash Flow | 6.7 Million | 52.5 Million | 78.93 Million | 50.16 Million | 174.73 Million | 56.44 Million |
| Debt repayment | -14.6 Million | -14.2 Million | -260.27 Million | -93.75 Million | -179.08 Million | -4.68 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -96.79 Million | - | - |
| Common Stock Issuance | - | 200 Thousand | 19 Thousand | 224.17 Million | - | - |
| Other Financing Activities | 21.3 Million | 66.5 Million | 339.19 Million | 33.07 Million | -4.35 Million | 61.13 Million |
| Accounts receivables | 23 Million | -38 Million | -31.6 Million | -29.43 Million | -2.93 Million | -7.47 Million |
| Accounts payables | - | - | 31.6 Million | 29.43 Million | 2.93 Million | - |
| Inventory | - | - | -23.66 Million | -20.54 Million | -19.33 Million | -7.5 Million |
| Other working capital | 23 Million | - | -29.02 Million | -58.89 Million | 3.9 Million | -5.6 Million |
| Cash at beginning of period | 22.3 Million | 11.1 Million | 10.67 Million | 13.61 Million | 2.51 Million | 2.71 Million |
| Cash at end of period | 27.5 Million | 22.3 Million | 11.13 Million | 10.67 Million | 13.61 Million | 2.51 Million |
| Capital Expenditure | -49.3 Million | -46.1 Million | -81.1 Million | -23.7 Million | -126.91 Million | -64.51 Million |
| Effect of forex changes on cash | - | - | - | 1000.00 | - | 1000.00 |
| Net cash flow / Change in cash | 5.2 Million | 11.2 Million | 454 Thousand | -2.93 Million | 11.09 Million | -200 Thousand |
| Free Cash Flow | -1.9 Million | -31 Million | -80.37 Million | -74.75 Million | -114.6 Million | -56.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 700 Thousand | -11.9 Million | 9.9 Million | -9 Million | 1.1 Million | -2.4 Million |
| Depreciation & Amortization | 16.7 Million | 16.9 Million | 11.3 Million | 50.2 Million | 13.7 Million | 12.7 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -15.8 Million | -7.3 Million | 45.1 Million | 23 Million | 3.8 Million | -24.2 Million |
| Other non-cash items | 1.1 Million | 9 Million | -19 Million | -16.8 Million | 1.7 Million | -900 Thousand |
| Investing Cash Flow | -3.8 Million | -4.6 Million | -23.8 Million | -48.9 Million | -10 Million | -6.7 Million |
| Investments in PPE | -3.7 Million | -4.7 Million | -24.4 Million | -49.3 Million | -9.9 Million | -6.7 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -100 Thousand | 100 Thousand | 600 Thousand | 400 Thousand | -100 Thousand | -600 Thousand |
| Financing Cash Flow | -11.2 Million | 10.5 Million | -14.6 Million | 6.7 Million | -6.4 Million | 6.6 Million |
| Debt repayment | -11.3 Million | -10.5 Million | -4.1 Million | -14.6 Million | -6.4 Million | -23.6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -100 Thousand | - | - | - |
| Common Stock Issuance | - | - | -100 Thousand | - | - | 100 Thousand |
| Other Financing Activities | 100 Thousand | 10.5 Million | -10.4 Million | 21.3 Million | - | 30.1 Million |
| Accounts receivables | -15.8 Million | -7.3 Million | 45.1 Million | 23 Million | 3.8 Million | -24.2 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 19.6 Million | 27.5 Million | 18.7 Million | 22.3 Million | 14.8 Million | 29.7 Million |
| Cash at end of period | 19.6 Million | 32 Million | 27.5 Million | 27.5 Million | 18.7 Million | 14.8 Million |
| Capital Expenditure | -3.7 Million | -4.7 Million | -24.4 Million | -49.3 Million | -9.9 Million | -6.7 Million |
| Effect of forex changes on cash | - | - | -100 Thousand | - | - | - |
| Net cash flow / Change in cash | - | 4.5 Million | 8.8 Million | 5.2 Million | 3.9 Million | -14.9 Million |
| Free Cash Flow | -1 Million | -6.2 Million | 22.9 Million | -1.9 Million | 10.4 Million | -21.5 Million |
MALLPLAZA
600716
GALAXYSURF
FPLSF
HQY
CLRD